Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with idiopathic Parkinson's disease (meaning the kind that is not inherited or linked to family genetics) by a specialist neurologist, using a specific set of established diagnostic guidelines
- People whose Parkinson's disease falls within a certain range of severity, rated between stages I and IV on a standard scale used by neurologists to measure how advanced the condition is
- People who have already been approved to have a specific type of brain surgery (called Deep Brain Stimulation, or DBS) targeting one of two particular areas of the brain, and who do not yet have any DBS devices already implanted
- People who have mild or moderate difficulties with their voice or swallowing
Who may not be able to join:
- People who have a neurological condition other than Parkinson's disease, including conditions such as essential tremor
- People who have severe mental health difficulties, unstable psychiatric conditions (such as severe depression), or moderate to severe problems with memory and thinking, as determined by their treating specialist
- People with a history of cancer of the head, neck, or lungs (though minor skin cancers of a specific type may not be a barrier — confirm with trial site)
- People with a history of a voice disorder unrelated to Parkinson's disease, whether structural, functional, or neurological in nature
- People with a history of a long-term, hard-to-treat chronic cough
- People with a history of a bleeding disorder
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Karen Hegland, Ph.D., University of Florida
Phone: 352-273-6561
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Glottal closure; Voluntary cough airflow; Swallowing safety
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.